FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080648967> ?p ?o ?g. }

• W2080648967 endingPage "166" @default.
• W2080648967 startingPage "159" @default.
• W2080648967 abstract "Dipeptidyl peptidase-4 (DPP-4) inhibitor is a new class of anti-diabetic drug which exerts its glucose-lowering action by suppressing the degradation of a gut incretin hormone glucagon-like peptide-1 (GLP-1). To elucidate whether treatment with stronger DPP-4 inhibitor on top of angiotensin II type 1 receptor blocker (ARB) provides greater renal protective effects, we performed a crossover study with two DPP-4 inhibitors, sitagliptin and alogliptin, in twelve type 2 diabetic patients with incipient nephropathy taking ARBs. This study consisted of three treatment periods: sitagliptin 50 mg/day for 4 weeks (first period), alogliptin 25 mg/day for 4 weeks (second period), and sitagliptin 50 mg/day for 4 weeks (third period). Significant changes in body mass index, blood pressure, serum lipids, serum creatinine, estimated glomerular filtration rate, and HbA1c were not observed among the three treatment periods. Reduced urinary levels of albumin and an oxidative stress marker 8-hydroxy-2’-deoxyguanosine (8-OHdG), increased urinary cAMP levels, and elevated plasma levels of stromal cell-derived factor-1α (SDF-1α) which is a physiological substrate of DPP-4 were observed after the switch from sitagliptin to a stronger DPP-4 inhibitor alogliptin. Given a large body of evidence indicating anti-oxidative action of cAMP and up-regulation of cellular cAMP production by SDF-1α, the present results suggest that more powerful DPP-4 inhibition on top of angiotensin II type 1 receptor blockade would offer additional protection against early-stage diabetic nephropathy beyond that attributed to glycemic control, via reduction of renal oxidative stress by SDF-1α-cAMP pathway activation." @default.
• W2080648967 created "2016-06-24" @default.
• W2080648967 creator A5009147637 @default.
• W2080648967 creator A5011927437 @default.
• W2080648967 creator A5015438909 @default.
• W2080648967 creator A5016507641 @default.
• W2080648967 creator A5032143287 @default.
• W2080648967 creator A5044415438 @default.
• W2080648967 creator A5044499778 @default.
• W2080648967 creator A5047731583 @default.
• W2080648967 creator A5048295812 @default.
• W2080648967 creator A5077457698 @default.
• W2080648967 creator A5083073341 @default.
• W2080648967 creator A5083573113 @default.
• W2080648967 date "2014-01-01" @default.
• W2080648967 modified "2023-10-01" @default.
• W2080648967 title "DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria <i>via</i> up-regulation of SDF-1α in type 2 diabetic patients with incipient nephropathy" @default.
• W2080648967 cites W1573925283 @default.
• W2080648967 cites W1976026431 @default.
• W2080648967 cites W1989438148 @default.
• W2080648967 cites W2003502792 @default.
• W2080648967 cites W2011601530 @default.
• W2080648967 cites W2023624246 @default.
• W2080648967 cites W2034269429 @default.
• W2080648967 cites W2034383851 @default.
• W2080648967 cites W2035040393 @default.
• W2080648967 cites W2045331345 @default.
• W2080648967 cites W2047730645 @default.
• W2080648967 cites W2048430011 @default.
• W2080648967 cites W2054989216 @default.
• W2080648967 cites W2083990676 @default.
• W2080648967 cites W2084948079 @default.
• W2080648967 cites W2087202910 @default.
• W2080648967 cites W2101094788 @default.
• W2080648967 cites W2102941723 @default.
• W2080648967 cites W2107259575 @default.
• W2080648967 cites W2110215067 @default.
• W2080648967 cites W2111538581 @default.
• W2080648967 cites W2114212244 @default.
• W2080648967 cites W2115408859 @default.
• W2080648967 cites W2117412164 @default.
• W2080648967 cites W2140563977 @default.
• W2080648967 cites W2141264129 @default.
• W2080648967 cites W2145824107 @default.
• W2080648967 cites W2146242381 @default.
• W2080648967 cites W2155210704 @default.
• W2080648967 cites W2157375360 @default.
• W2080648967 cites W2157966156 @default.
• W2080648967 cites W2158498099 @default.
• W2080648967 cites W2159205789 @default.
• W2080648967 cites W2166051277 @default.
• W2080648967 cites W840007291 @default.
• W2080648967 doi "https://doi.org/10.1507/endocrj.ej13-0305" @default.
• W2080648967 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24225429" @default.
• W2080648967 hasPublicationYear "2014" @default.
• W2080648967 type Work @default.
• W2080648967 sameAs 2080648967 @default.
• W2080648967 citedByCount "79" @default.
• W2080648967 countsByYear W20806489672014 @default.
• W2080648967 countsByYear W20806489672015 @default.
• W2080648967 countsByYear W20806489672016 @default.
• W2080648967 countsByYear W20806489672017 @default.
• W2080648967 countsByYear W20806489672018 @default.
• W2080648967 countsByYear W20806489672019 @default.
• W2080648967 countsByYear W20806489672020 @default.
• W2080648967 countsByYear W20806489672021 @default.
• W2080648967 countsByYear W20806489672022 @default.
• W2080648967 countsByYear W20806489672023 @default.
• W2080648967 crossrefType "journal-article" @default.
• W2080648967 hasAuthorship W2080648967A5009147637 @default.
• W2080648967 hasAuthorship W2080648967A5011927437 @default.
• W2080648967 hasAuthorship W2080648967A5015438909 @default.
• W2080648967 hasAuthorship W2080648967A5016507641 @default.
• W2080648967 hasAuthorship W2080648967A5032143287 @default.
• W2080648967 hasAuthorship W2080648967A5044415438 @default.
• W2080648967 hasAuthorship W2080648967A5044499778 @default.
• W2080648967 hasAuthorship W2080648967A5047731583 @default.
• W2080648967 hasAuthorship W2080648967A5048295812 @default.
• W2080648967 hasAuthorship W2080648967A5077457698 @default.
• W2080648967 hasAuthorship W2080648967A5083073341 @default.
• W2080648967 hasAuthorship W2080648967A5083573113 @default.
• W2080648967 hasBestOaLocation W20806489671 @default.
• W2080648967 hasConcept C126322002 @default.
• W2080648967 hasConcept C134018914 @default.
• W2080648967 hasConcept C156490143 @default.
• W2080648967 hasConcept C159641895 @default.
• W2080648967 hasConcept C185592680 @default.
• W2080648967 hasConcept C2776174234 @default.
• W2080648967 hasConcept C2777180221 @default.
• W2080648967 hasConcept C2778881409 @default.
• W2080648967 hasConcept C2779284873 @default.
• W2080648967 hasConcept C2779922275 @default.
• W2080648967 hasConcept C2780012697 @default.
• W2080648967 hasConcept C555293320 @default.
• W2080648967 hasConcept C71924100 @default.
• W2080648967 hasConcept C98274493 @default.
• W2080648967 hasConceptScore W2080648967C126322002 @default.
• W2080648967 hasConceptScore W2080648967C134018914 @default.

• next